X4 Pharmaceuticals (XFOR) Tops Q1 EPS by 16c
Tweet
Share
E-mailGet Alerts XFOR Hot Sheet
Join SI Premium – FREE
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q1 EPS of $0.04, $0.16 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $28.81 million versus the consensus estimate of $12.03 million.
For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Emerson (EMR) to Overweight
- RBC Capital Assumes Zip Co Ltd (ZIP:AU) (ZIZTF) at Outperform
- Netflix (NFLX) PT Lowered to $95 at Bernstein SocGen Group
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
